பெர்ல்மேன் பள்ளி ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பெர்ல்மேன் பள்ளி ஆஃப் மருந்து. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பெர்ல்மேன் பள்ளி ஆஃப் மருந்து Today - Breaking & Trending Today

Two Yenching Scholars for Penn


Share
University of Pennsylvania senior Patrick Beyrer and 2020 graduate Brook Jiang have been selected as 2021 Yenching Scholars, with full funding to pursue an interdisciplinary master’s degree in China studies at the Yenching Academy of Peking University, in Beijing.
Beyrer and Jiang are among the 117 scholars chosen from 37 countries to enroll in the one-year program in September. Six scholars affiliated with Penn have been chosen since the program’s inception in 2015.
Beyrer, from Rockville Centre, New York, is pursuing a combined bachelor’s and master’s degree in East Asian languages and civilizations with a concentration in Chinese and a minor in science, technology, and society in the School of Arts & Sciences. At Penn, he has been involved in radiology research at the Perlman School of Medicine and was the vice president of mentorship for Penn Transfer Student Organization. ....

New York , United States , New Jersey , Rockville Centre , Patrick Beyrer , Japan Foundation Kakehashi Project Scholar , World Foundation , Penn Transfer Student Organization , Yenching Academy , Wharton School , Penn Center , College Of Arts , Penn Ivy Council , Wharton Asia Exchange , Yenching Academy Of Peking University , Department Of Education , Huntsman Program For International , Organizational Behavior Research , School Of Arts Sciences , Perlman School Of Medicine , University Of Pennsylvania , Brook Jiang , Peking University , East Asian , Perlman School , Penn Transfer Student ,

Covid Vaccination: Challenges for India by Gollamudi Radha Krishna Murty


by
As the news of four vaccine candidates claiming high efficacy levels in field trials cheered up the pandemic-struck globe, India, with more than 9 million confirmed Covid-19 cases, and a battered economy, is getting ready to vaccinate a population of more than a billion people, that too, twice. And that too, quite rapidly, for that is believed to be the sure-shot way to arrest the pandemic spread.
No doubt, India, as the world’s leading vaccine manufacturer, is in a better position vis-à-vis many other developing countries for accessing vaccines. Serum Institute of India alone is planning to produce a billion doses of Novavax vaccine by 2021 and Bharat Biotech Ltd is getting ready to produce its own vaccine soon, but challenges galore in the path: distribution logistics, supply of the right vaccine with a proven efficacy level with no accompanying side-effects and cost of the vaccine. ....

Uttar Pradesh , Paul Offit , Perlman School Of Medicine , Bharat Biotech Ltd , University Of Pennsylvania , Immunization Programme , Serum Institute Of India , Prime Minister , Universal Immunization Programme , Perlman School , உத்தர் பிரதேஷ் , பால் ஒப்பித் , பெர்ல்மேன் பள்ளி ஆஃப் மருந்து , பாரத் பயோடெக் லிமிடெட் , பல்கலைக்கழகம் ஆஃப் பென்சில்வேனியா , நோய்த்தடுப்பு ப்ரோக்ராம் , சீரம் நிறுவனம் ஆஃப் இந்தியா , ப்ரைம் அமைச்சர் , உலகளாவிய நோய்த்தடுப்பு ப்ரோக்ராம் , பெர்ல்மேன் பள்ளி ,